Active substanceZinc pyrithioneZinc pyrithione
Similar drugsTo uncover
  • Skin-cap
    shampoo externally 
    INVAR, LLC     Russia
  • Skin-cap
    cream externally 
    INVAR, LLC     Russia
  • Skin-cap
    aerosol externally 
    INVAR, LLC     Russia
  • Zinocap®
    cream externally 
  • Zinocap®
    aerosol externally 
  • Dosage form: & nbsp

    Cream for external use.

    Composition:

    100 g of cream contain:

    active substance - zinc pyrithione (in terms of 100 % substance) 0.2 g (0.2%); Excipients: macrogol cetostearate, cetostearyl alcohol, paraffin liquid (Vaseline oil), propylene glycol, dexpanthenol (D-Panthenol), sodium dihydrogen phosphate dihydrate, sodium hydrogen phosphate dodecahydrate, purified water.

    Description:

    Cream white or white with a yellowish tint of color, odorless or with a weak specific odor.

    Pharmacotherapeutic group:Dermatoprotective agent.
    ATX: & nbsp

    D.11.A.X.12   Zinc pyrithione

    Pharmacodynamics:

    Pyrithione zinc has anti-inflammatory, antibacterial and antifungal activity. Antibacterial activity of zinc pyrithione is manifested in a number of Gram-positive and Gram-negative bacteria (Streptococcus spp., Staphylococcus spp., Escherichia coli, Pseudomonas aeruginosa, Proteus spp.). Pyrithione zinc reduces the intracellular level of ATP, contributes to the depolarization of cell membranes, causing the death of fungi and bacteria. Antifungal activity is especially pronounced in the case of fungi of the genus Malassezia (formerly Pityrosporum ovale and Pityrosporum orbiculare),causing inflammation and excessive desquamation in dandruff, seborrheic dermatitis, psoriasis and other skin diseases. The mechanism of anti-inflammatory action has not been studied.

    Pharmacokinetics:

    Systemic absorption is negligible. The drug is found in the blood in trace amounts.

    Indications:

    • psoriasis
    • atopic dermatitis (eczema, neurodermatitis)
    • seborrheic dermatitis
    • dry skin

    Contraindications:

    Hypersensitivity, children under 1 year.

    Dosing and Administration:

    The drug is intended for external use.

    Applied in adults and children from 1 year.

    The cream is applied a thin layer on the affected areas 2-3 times a day.

    Duration of treatment with:

    • psoriasis - 1-1,5 months, repeated courses - with the appearance of signs of exacerbation;
    • atopic dermatitis - 3-4 weeks;
    • seborrheic dermatitis - 2 weeks.

    Side effects:

    The drug is usually well tolerated. Sometimes there are allergic reactions.

    Overdose:To date, no cases of overdose of zinc pyrithione have been reported.
    Interaction:

    Clinically significant interaction of zinc pyrithione with other drugs has not been identified.

    Form release / dosage:

    Cream for external use 0,2%.

    Packaging:

    25 g or 50 g in aluminum tubes.

    Tubu together with instructions for use are placed in a pack of cardboard.

    Storage conditions:

    At a temperature of 4 to 25 ° C.

    Keep out of the reach of children.

    Shelf life:

    3 years. Do not use after the expiration date printed on the package.

    Terms of leave from pharmacies:On prescription
    Registration number:LSR-010496/08
    Date of registration:24.12.2008
    The owner of the registration certificate:Otisipharm, PAO Otisipharm, PAO
    Manufacturer: & nbsp
    Information update date: & nbsp15.10.2015
    Illustrated instructions
      Instructions
      Up